Official farewell page says services discontinued after GLP-1shortages ended.
Our read: Official farewell page says services discontinued after GLP-1shortages ended.
Closed. Historical FTC evidence described $138/$188 monthly membership excluding drugs, labs and consultation. Not current offers.
- https://nextmed.com/ ↗
- https://www.ftc.gov/legal-library/browse/cases-proceedings/nextmed ↗
- https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive ↗
- https://www.ftc.gov/news-events/news/press-releases/2025/07/ftc-takes-action-against-telemedicine-firm-nextmed-over-charges-it-used-misleading-prices-fake ↗
Historical medical-provider access; current treating entity not established after closure.
- https://nextmed.com/ ↗
- https://www.ftc.gov/legal-library/browse/cases-proceedings/nextmed ↗
- https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive ↗
- https://www.ftc.gov/news-events/news/press-releases/2025/07/ftc-takes-action-against-telemedicine-firm-nextmed-over-charges-it-used-misleading-prices-fake ↗
No current fulfillment. Historical pharmacy-choice and Labcorp/Quest links claimed on farewell page.
- https://nextmed.com/ ↗
- https://www.ftc.gov/legal-library/browse/cases-proceedings/nextmed ↗
- https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive ↗
- https://www.ftc.gov/news-events/news/press-releases/2025/07/ftc-takes-action-against-telemedicine-firm-nextmed-over-charges-it-used-misleading-prices-fake ↗
Channel-specific public-library evidence below; counts are observations, never spend/performance.
- https://adstransparency.google.com/?region=US&domain=nextmed.com&preset-date=Last+30+days ↗
- https://www.facebook.com/ads/library/?active_status=active&ad_type=all&country=US&is_targeted_country=false&media_type=all&q=NextMed&search_type=keyword_exact_phrase ↗
- https://www.linkedin.com/ad-library/search?accountOwner=NextMed ↗
Not established in the public sources checked.
Robert Epstein identified as founder by FTC; Frank Leonardo III identified as CEO/principal. Not interchangeable roles.
New York-based historically, per FTC July 2025; not current active HQ.
Official farewell page is live; current marketing/service footprint is historical. Rankings, traffic and authority not measured.